iBio, Inc.

Historical 13F Holders

Symbol
IBIO
CUSIP
451033708
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 451033708 since 12/18/2024, largest first.

Filer % of Class Filed
Cormorant Asset Management, LP 13G/A
10.0% 8/14/2026
Event 6/30/2026
Affinity Asset Advisors, LLC 13G/A
10.0% 8/13/2026
Event 6/30/2026
Adage Capital Management, L.P. 13G
10.0% 11/13/2025
Event 9/30/2025
SilverArc Capital Management, LLC 13G
10.0% 11/14/2025
Event 9/30/2025
Sirenia Capital Management LP 13G
9.9% 5/15/2026
Event 3/31/2026
Vestal Point Capital, LP 13G/A
7.9% 8/14/2026
Event 6/30/2026
Opaleye Management Inc. 13G/A 7.6% 2/14/2025
Event 12/31/2024
Frazier Life Sciences Public Fund, L.P. 13G/A
5.7% 5/12/2026
Event 3/31/2026
Lynx1 Capital Management LP 13G
5.4% 8/14/2026
Event 6/30/2026
Integrated Core Strategies (US) LLC 13G
5.2% 1/22/2026
Event 1/15/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Ikarian Capital, LLC 13G/A
4.99% 11/14/2025
Event 9/30/2025
EcoR1 Capital, LLC 13G/A
4.6% 5/15/2026
Event 3/31/2026
ADAR1 Capital Management, LLC 13G/A
4.4% 2/17/2026
Event 12/31/2025
Patrick J. Crutcher 13G/A 3.1% 7/30/2025
Event 6/30/2025
Logos Global Management LP 13G/A
0% 5/15/2026
Event 3/31/2026
Point72 Asset Management, L.P. 13G/A
0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 55 34.7 M $60.8 M
2026 Q1 52 19.4 M $36.9 M
2025 Q4 50 16.3 M $31.6 M
2025 Q3 33 3.57 M $2.96 M
2025 Q2 31 3.20 M $2.44 M
2025 Q1 35 2.59 M $10.4 M
2024 Q4 31 2.61 M $6.40 M
2024 Q3 34 2.61 M $5.79 M
2024 Q2 32 2.69 M $5.68 M
2024 Q1 33 2.89 M $11.5 M
2023 Q4 27 252 k $345 k
2023 Q2 1 8.00 $5.00
2023 Q1 1 8.00 $17.00